XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 28, 2024 | (Q4)Dec 28, 2024 | (Q3)Sep 28, 2024 | (Q2)Jun 29, 2024 | (Q1)Mar 30, 2024 | (FY)Dec 30, 2023 | (Q4)Dec 30, 2023 | (Q3)Sep 30, 2023 | (Q2)Jul 1, 2023 | (Q1)Apr 1, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 21.01%987.32M | 20.60%263.94M | 21.73%252.21M | 27.10%242.33M | 14.90%228.85M | -18.83%815.87M | -13.59%218.86M | -18.51%207.19M | -25.61%190.66M | 199.17M |
Operating revenue | 21.01%987.32M | 20.60%263.94M | 21.73%252.21M | 27.10%242.33M | 14.90%228.85M | -18.83%815.87M | -13.59%218.86M | -18.51%207.19M | -25.61%190.66M | --199.17M |
Cost of revenue | 19.31%472.01M | 18.61%131.53M | 15.45%115.83M | 26.49%114.09M | 17.38%110.56M | -15.10%395.61M | -4.44%110.89M | -13.06%100.33M | -27.36%90.2M | 94.19M |
Gross profit | 22.62%515.31M | 22.64%132.41M | 27.63%136.38M | 27.65%128.24M | 12.68%118.29M | -22.06%420.25M | -21.32%107.97M | -23.04%106.85M | -23.97%100.46M | 104.98M |
Operating expense | 7.90%328.21M | 12.81%89.95M | 14.36%83.31M | 4.96%79.4M | -0.52%75.55M | 0.55%304.18M | 4.90%79.74M | -8.42%72.85M | 1.31%75.65M | 75.94M |
Selling and administrative expenses | 11.79%162M | 6.12%44.96M | 27.46%41.92M | 12.82%39.25M | 2.89%35.88M | 7.13%144.91M | 23.29%42.37M | -2.04%32.89M | -1.23%34.79M | --34.87M |
-Selling and marketing expense | 23.30%76.16M | 26.45%19.41M | 31.83%19.45M | 18.42%18.98M | 17.15%18.32M | -5.97%61.77M | -6.26%15.35M | -12.01%14.76M | -5.26%16.02M | --15.64M |
-General and administrative expense | 3.25%85.85M | -5.44%25.55M | 23.90%22.47M | 8.04%20.27M | -8.70%17.56M | 19.49%83.15M | 50.19%27.02M | 7.92%18.13M | 2.49%18.76M | --19.24M |
Research and development costs | 11.80%116.77M | 45.26%34.89M | 8.19%28.28M | 0.00%27.04M | -2.53%26.55M | -6.71%104.44M | -13.67%24.02M | -18.71%26.14M | 5.48%27.04M | --27.24M |
Depreciation amortization depletion | -9.82%49.44M | -24.35%10.1M | -5.14%13.11M | -5.16%13.11M | -5.15%13.11M | -0.84%54.82M | -3.43%13.35M | 0.01%13.82M | 0.04%13.83M | --13.82M |
-Depreciation and amortization | -9.82%49.44M | -24.35%10.1M | -5.14%13.11M | -5.16%13.11M | -5.15%13.11M | -0.84%54.82M | -3.43%13.35M | 0.01%13.82M | 0.04%13.83M | --13.82M |
Operating profit | 61.19%187.1M | 50.41%42.46M | 56.07%53.07M | 96.85%48.83M | 47.19%42.74M | -50.96%116.08M | -53.88%28.23M | -42.66%34.01M | -56.82%24.81M | 29.04M |
Net non-operating interest income expense | 64.52%33.49M | 38.86%8.97M | 52.21%8.67M | 78.56%8.5M | 113.49%7.36M | 306.23%20.36M | 162.76%6.46M | 275.59%5.69M | 619.82%4.76M | 3.45M |
Non-operating interest income | 64.52%33.49M | 38.86%8.97M | 52.21%8.67M | 78.56%8.5M | 113.49%7.36M | 306.23%20.36M | 162.76%6.46M | 275.59%5.69M | 619.82%4.76M | --3.45M |
Other net income (expense) | 96.24%-145K | 82.09%-154K | 27.67%-724K | 96.49%-60K | 382.21%793K | -2,631.91%-3.85M | -145.65%-860K | -4.05%-1M | -99.07%-1.71M | -281K |
Gain on sale of security | ---- | ---- | 30.23%-704K | 97.00%-54K | 309.12%642K | -5,504.11%-4.09M | -149.54%-975K | 0.69%-1.01M | -121.95%-1.8M | ---307K |
Other non- operating income (expenses) | -160.67%-145K | -233.91%-154K | -350.00%-20K | -106.67%-6K | 480.77%151K | 451.47%239K | 236.90%115K | -85.19%8K | 287.50%90K | --26K |
Income before tax | 66.27%220.45M | 51.57%51.27M | 57.67%61.02M | 105.60%57.27M | 58.04%50.89M | -45.12%132.58M | -48.40%33.83M | -35.35%38.7M | -51.35%27.86M | 32.2M |
Income tax | 64.38%18.78M | -30.22%2.45M | 183.11%7.96M | 120.52%4.32M | 28.88%4.04M | -37.41%11.42M | 632.07%3.52M | -63.21%2.81M | -65.50%1.96M | 3.13M |
Net income | 66.45%201.67M | 61.06%48.82M | 47.83%53.05M | 104.47%52.95M | 61.18%46.85M | -45.75%121.16M | -54.23%30.31M | -31.27%35.89M | -49.79%25.9M | 29.07M |
Net income continuous Operations | 66.45%201.67M | 61.06%48.82M | 47.83%53.05M | 104.47%52.95M | 61.18%46.85M | -45.75%121.16M | -54.23%30.31M | -31.27%35.89M | -49.79%25.9M | --29.07M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 66.45%201.67M | 61.06%48.82M | 47.83%53.05M | 104.47%52.95M | 61.18%46.85M | -45.75%121.16M | -54.23%30.31M | -31.27%35.89M | -49.79%25.9M | 29.07M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 66.45%201.67M | 61.06%48.82M | 47.83%53.05M | 104.47%52.95M | 61.18%46.85M | -45.75%121.16M | -54.23%30.31M | -31.27%35.89M | -49.79%25.9M | 29.07M |
Basic earnings per share | 65.59%4.09 | 59.68%0.99 | 46.58%1.07 | 101.89%1.07 | 58.33%0.95 | -45.35%2.47 | -54.07%0.62 | -30.48%0.73 | -49.04%0.53 | 0.6 |
Diluted earnings per share | 65.04%4.06 | 60.66%0.98 | 46.58%1.07 | 101.89%1.07 | 59.32%0.94 | -45.21%2.46 | -54.48%0.61 | -30.48%0.73 | -48.54%0.53 | 0.59 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |